Dong-A ST Co., Ltd.
- Country
- š°š·South Korea
- Ownership
- Public
- Established
- 1932-01-01
- Employees
- 1.6K
- Market Cap
- -
- Website
- http://www.donga-st.com
The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients
- First Posted Date
- 2019-12-12
- Last Posted Date
- 2021-12-01
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 17
- Registration Number
- NCT04195919
- Locations
- š°š·
Seoul National University Hospital, Seoul, Korea, Republic of
Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
- Conditions
- Interventions
- First Posted Date
- 2019-11-20
- Last Posted Date
- 2021-12-10
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 283
- Registration Number
- NCT04170998
- Locations
- š°š·
Seoul St, Mary's Hospital,The Catholic University of Korea, Seoul, Korea, Republic of
BE Study of GasterĀ®D Tab 20mg (Manufacturer Changed)
- First Posted Date
- 2019-10-11
- Last Posted Date
- 2019-10-11
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT04123899
Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD
- First Posted Date
- 2019-08-14
- Last Posted Date
- 2023-03-03
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 228
- Registration Number
- NCT04055883
- Locations
- š°š·
Chonnam National University Hospital, Gwangju, Donggu, Korea, Republic of
š°š·Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of
š°š·Kyeongpook National University Hospital, Daegu, Jung-gu, Korea, Republic of
Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults
- First Posted Date
- 2019-07-09
- Last Posted Date
- 2021-04-14
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT04013477
- Locations
- š°š·
Clinical Trials Center, Severance Hospital, Seoul, Korea, Republic of
A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fed State
- Conditions
- Interventions
- First Posted Date
- 2019-05-09
- Last Posted Date
- 2020-05-20
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT03944200
- Locations
- š°š·
Metro Hospital, Anyang si, Gyeonggi-do, Korea, Republic of
A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fasting State
- Conditions
- Interventions
- First Posted Date
- 2019-05-06
- Last Posted Date
- 2020-05-20
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 34
- Registration Number
- NCT03939143
- Locations
- š°š·
Metro Hospital, Anyang-si, Gyeonggi-do, Korea, Republic of
Bioequivalence Test of "Dong-a Bepotastine Besilate Tab" and "Twolion Tab"
- Conditions
- Interventions
- First Posted Date
- 2019-04-30
- Last Posted Date
- 2020-02-10
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT03932435
- Locations
- š°š·
H Plus Yangji Hospital, Seoul, Korea, Republic of
Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases
- Conditions
- Interventions
- First Posted Date
- 2019-04-10
- Last Posted Date
- 2021-04-29
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 51
- Registration Number
- NCT03910361
- Locations
- š°š·
Soonchunhyang University Hospital, Cheonan, Korea, Republic of
š°š·Hanyang University Guri Hospital, Guri-si, Korea, Republic of
š°š·Samsung Medical Center, Changwon, Korea, Republic of
Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male Adults
- First Posted Date
- 2018-12-06
- Last Posted Date
- 2019-04-10
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 42
- Registration Number
- NCT03766724
- Locations
- š°š·
Clinical Trials Center, Severance Hospital, Seoul, Korea, Republic of